Oppenheimer Maintains Outperform on Gladstone Inv, Raises Price Target to $17

Benzinga Newsdesk www.benzinga.com Positive 90.5%

Neg 0% Neu 0% Pos 90.5%

Oppenheimer analyst Mitchel Penn maintains Gladstone Inv (NASDAQ:GAIN) with a Outperform and raises the price target from $15 to $17.